Trade Secret Protection Agreement (UAE)

A Trade Secret Protection Agreement in the United Arab Emirates is a specialised legal instrument through which the owner of commercially sensitive proprietary information — formulas, algorithms, processes, methods, client databases, or know-how — discloses that information to a recipient on strictly controlled terms, and the recipient undertakes to protect it to the highest standard, use it only for the defined purpose, and return or destroy it when the purpose is complete. The agreement operates under two intersecting legal frameworks: the Federal Law on Industrial Property and Trade Secrets (Federal Law No. 11 of 2021), which provides statutory protection for trade secrets and criminal sanctions for deliberate misappropriation, and the UAE Civil Code (Federal Law No. 5 of 1985), which provides the contractual enforcement mechanism through compensation and injunctive relief.

The Federal Law on Industrial Property and Trade Secrets (Federal Law No. 11 of 2021) is the primary statute. Article 63 of Federal Law No. 11 of 2021 defines a trade secret as information that: is not generally known or readily accessible to persons who normally deal with the relevant type of information; has commercial value because of its secrecy; and has been subject to reasonable steps by the holder to maintain its confidentiality. The statute prohibits the unauthorised acquisition, use, or disclosure of trade secrets by methods contrary to fair commercial practice, including theft, bribery, electronic intrusion, breach of agreement, or inducing a third party to disclose. Civil and criminal remedies are available, with the Ministry of Economy coordinating enforcement at the federal level.

A Trade Secret Protection Agreement differs from a standard NDA in three important respects. First, it expressly categorises the protected information as a trade secret within the statutory definition, activating the criminal and regulatory remedies of Federal Law No. 11 of 2021 alongside the contractual remedies of the Civil Code. Second, it typically provides for indefinite protection tied to the persistence of the trade secret character, rather than a fixed period that could leave a valuable formula unprotected after a calendar end date. Third, it includes an improvement assignment clause ensuring that derivative works, modifications, and developments created by the recipient that incorporate the owner's trade secrets vest in the owner automatically, preventing the recipient from claiming separate rights over innovations built on the owner's proprietary foundation.

The UAE's knowledge economy — encompassing pharmaceutical research in Dubai Science Park, fintech development in the DIFC, advanced manufacturing in Abu Dhabi, and logistics technology in the Jebel Ali Free Zone (JAFZA) — generates substantial volumes of trade secret information. Companies operating in these sectors engage contract research organisations, technology partners, and specialist consultants who require access to proprietary know-how. The Trade Secret Protection Agreement provides the legal architecture for those engagements while preserving the owner's enforcement rights before the Dubai Courts, the Abu Dhabi Judicial Department, or an arbitral tribunal under the Federal Arbitration Law (Federal Law No. 6 of 2018).

The Personal Data Protection Law (Federal Decree-Law No. 45 of 2021), administered by the UAE Data Office, adds a further layer where the trade secrets include personal data — such as patient data in clinical research, customer behavioural data in retail analytics, or employee data in HR systems. The Electronic Transactions and Trust Services Law (Federal Decree-Law No. 46 of 2021) validates electronic execution, making the agreement accessible to cross-border research and technology partnerships without the need for physical notarization.

A Trade Secret Protection Agreement in the United Arab Emirates is needed whenever an owner discloses information that qualifies as a trade secret under Federal Law No. 11 of 2021 and requires the statutory remedies, not merely the contractual remedies available under a standard NDA.

Pharmaceutical and life sciences companies operating in the UAE — particularly those based in Dubai Science Park, Dubai Healthcare City, or Abu Dhabi's Hub71 health cluster — share drug formulations, synthesis processes, clinical trial protocols, and manufacturing know-how with contract research organisations, testing laboratories, and regulatory affairs consultants. A Trade Secret Protection Agreement ensures that the disclosed information is categorised as a statutory trade secret from the outset, activating the maximum level of protection.

Technology companies that disclose proprietary source code, machine learning models, AI training datasets, or patented algorithms to a development partner, a cloud service provider, or a system integrator in the UAE need a Trade Secret Protection Agreement rather than a generic NDA, because the commercial value of the intellectual assets is so high that the additional statutory remedies of Federal Law No. 11 of 2021 — including criminal sanctions — provide a meaningful deterrent.

Manufacturing companies with proprietary production processes, quality control formulas, or supply chain methods that they share with contract manufacturers in the UAE require a Trade Secret Protection Agreement to protect know-how that may be worth more than any registered patent. The Jebel Ali Free Zone (JAFZA) and the Abu Dhabi Khalifa Industrial Zone (KIZAD) host significant manufacturing operations where proprietary production methods are the competitive foundation.

Food and beverage companies sharing recipes, flavour formulations, or fermentation processes with contract manufacturers or distributors in the UAE have trade secrets that may be permanently unpatentable or where patent publication would expose the formula. A Trade Secret Protection Agreement provides long-term protection without patent disclosure.

Financial institutions and fintech companies sharing proprietary risk models, trading algorithms, and pricing engines with technology vendors or third-party system integrators in the DIFC or onshore UAE use Trade Secret Protection Agreements to protect intellectual assets that underpin their competitive position.

A Trade Secret Protection Agreement for the United Arab Emirates must contain the following elements to activate both the contractual and statutory protection frameworks. The forms-legal.com UAE trade secret template addresses each component.

Party identification must record the owner's and recipient's full legal names, trade licence numbers, and registered addresses with precision. The signatory on behalf of each party must hold board authorisation or a power of attorney under the Commercial Companies Law (Federal Decree-Law No. 32 of 2021).

Statutory categorisation must expressly state that the protected information constitutes trade secrets within the meaning of Article 63 of Federal Law No. 11 of 2021. This language bridges the contractual and statutory frameworks, ensuring that any enforcement action can invoke both regimes simultaneously.

Definition of Trade Secrets must be specific by category — pharmaceutical formulations, source code, manufacturing processes, client databases, or whatever the relevant type of information is — and should include all forms of the information: written records, electronic files, oral disclosures, and derivative works. The agreement should state that the information satisfies the three-part test: it is not publicly known; it has commercial value because of its secrecy; and the owner has taken reasonable steps to protect it.

Permitted purpose must restrict the recipient to a specific, defined use of the trade secrets. The narrower the purpose, the more clearly any deviation from it constitutes a breach.

Protection obligations must set a higher standard than the general NDA 'reasonable care' benchmark. The agreement should specify: the highest level of care consistent with the commercial value of the information; named access restrictions; written access logs; prohibition on reverse engineering or decompilation; and specific technical and physical security measures.

Indefinite or extended protection period tied to the persistence of the trade secret character is appropriate for genuinely valuable proprietary information. A fixed calendar period may leave high-value trade secrets unprotected after expiry.

Improvement assignment must vest in the owner all improvements, modifications, and derivative works created by the recipient that incorporate or are based on the trade secrets, from the moment of creation.

Return and destruction must require certified destruction of all copies on completion of the purpose or on request.

Remedies must preserve the full range: contractual compensation under Articles 282 and 389 of the UAE Civil Code (Federal Law No. 5 of 1985), injunctive and precautionary measures, and statutory remedies under Federal Law No. 11 of 2021 including Ministry of Economy enforcement.

Governing law and forum must identify UAE law and the Federal Law No. 11 of 2021 framework as applicable, and select the appropriate court or arbitration.

Completing a Trade Secret Protection Agreement for use in the United Arab Emirates requires careful attention to the definition of the trade secrets and the description of the permitted purpose, as these two fields determine the scope and enforceability of the entire agreement.

Enter the owner's full legal name exactly as it appears on the trade licence — for a mainland LLC, the DED licence; for a free-zone company, the DMCC, DHCC, JAFZA, or other applicable free-zone registration certificate. Add the licence number and registered address. Confirm that the person signing on behalf of the owner holds board authorisation or a power of attorney consistent with the Commercial Companies Law (Federal Decree-Law No. 32 of 2021). Enter the same information for the recipient.

Enter the date of the agreement in DD/MM/YYYY format. This date marks the commencement of the protection obligations and is the reference point for the return and destruction obligation when the purpose is completed.

Describe the trade secrets with commercial and technical precision. Rather than writing 'proprietary information', write the specific category — for example, 'pharmaceutical synthesis route for compound X, manufacturing process flow diagrams dated [date], and associated quality control protocols contained in documents [reference]'. The description should be detailed enough to identify a breach — if the recipient discloses information, the owner must be able to demonstrate that the disclosed information falls within the definition.

Describe the permitted purpose with equal specificity. 'Contract research services for bioequivalence testing of Compound X against the Owner's reference product in Phase II clinical trials conducted at [laboratory]' is far more useful than 'research purposes'. A narrow purpose statement supports enforcement and limits the scope of the recipient's permitted use.

Select the protection period. For pharmaceutical formulas, source code, or manufacturing know-how of genuine long-term commercial value, the indefinite option — protecting for as long as the information retains its trade secret character — is strongly advisable.

Select the governing courts appropriate to the owner's establishment. Both parties should sign through their authorised representatives. Electronic signatures are valid under the Electronic Transactions and Trust Services Law (Federal Decree-Law No. 46 of 2021).

A Trade Secret Protection Agreement in the United Arab Emirates operates under the most robust legal framework available for protecting commercially valuable confidential information.

The Federal Law on Industrial Property and Trade Secrets (Federal Law No. 11 of 2021) is the primary statute. Article 63 defines a trade secret by its secrecy, commercial value, and the steps taken to protect it. The statute prohibits unauthorised acquisition, use, and disclosure, and provides both civil and criminal remedies. The Ministry of Economy administers enforcement at the federal level. Deliberate misappropriation can attract criminal sanctions, including fines and potential imprisonment.

The UAE Civil Code (Federal Law No. 5 of 1985) provides the contractual enforcement mechanism. Article 125 confirms formation. Article 246 requires good-faith performance. Articles 282 and 389 provide compensation for breach. Article 390 allows the court to adjust any penalty clause. The Commercial Transactions Law (Federal Decree-Law No. 50 of 2022) supplements the Civil Code in commercial contexts.

The Personal Data Protection Law (Federal Decree-Law No. 45 of 2021), administered by the UAE Data Office, applies when the trade secrets include personal data. The DIFC Data Protection Law (DIFC Law No. 5 of 2020) and the ADGM Data Protection Regulations 2021 apply in those free zones.

The Federal Law on Copyrights and Related Rights (Federal Law No. 38 of 2021) governs ownership of derivative works and improvements. Without an express improvement assignment clause, the recipient may claim rights in improvements incorporating the owner's trade secrets.

The Commercial Companies Law (Federal Decree-Law No. 32 of 2021) governs corporate authority to execute the agreement. Electronic signatures are valid under the Electronic Transactions and Trust Services Law (Federal Decree-Law No. 46 of 2021). The Federal Arbitration Law (Federal Law No. 6 of 2018) governs arbitration proceedings. UAE arbitral awards are enforceable under the New York Convention in more than 170 states.

Trade Secret Protection Agreements are a specialised instrument that is often replaced by a generic NDA, leaving significant statutory protection unused. The following errors are most common.

1. Using a generic NDA instead of a Trade Secret Protection Agreement. A standard NDA does not expressly categorise the information as a trade secret under Federal Law No. 11 of 2021 and does not activate the statute's criminal sanctions and Ministry of Economy enforcement pathway. For genuinely high-value proprietary information, a dedicated trade secret agreement is materially stronger.

2. Fixed calendar protection period for indefinite-value secrets. A pharmaceutical formula protected for five years under an NDA is unprotected in year six. Trade secrets should be protected for as long as they retain their confidential character, not for an arbitrary calendar period.

3. Vague description of the trade secrets. 'All proprietary information' is unenforceable before the Dubai Courts if the owner cannot identify specific information that was disclosed and that qualifies as a trade secret. Always describe the trade secrets by category and, where possible, by document reference or technical specification.

4. No improvement assignment. Allowing the recipient to work with trade secrets without assigning improvements to the owner creates a risk that the recipient will develop and own improvements built on the owner's foundation, potentially devaluing or exposing the original trade secrets.

5. Insufficient security measures. A standard 'reasonable care' obligation is inadequate for high-value trade secrets. Require specific technical, physical, and organisational security measures proportionate to the sensitivity of the disclosed information.

6. No Federal Law No. 11 of 2021 reference. Without the statutory reference, the agreement functions only as a Civil Code contract, forfeiting the criminal and regulatory remedies available under the trade secrets statute.

7. Not creating a trade secret register before disclosure. The owner must be able to prove that the information was identified as a trade secret before the breach. A contemporaneous internal register maintained before any disclosure provides that evidence.